John Gowans, MD
Physical Medicine & Rehabilitation · Greenwood, SCNPI 1093001208
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $122 and has fallen 71.7% since, to $35 in 2025.
Across 16 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nalu Medical, Inc.$95
- Boston Scientific$81
- Amgen$72
- Abbott$61
- Medtronic$36
- Livanova USA, Inc.$27
- plus $66 from 4 others
What the payments were for
- Food & beverage$437100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nalu Medical, Inc. | 1 | $95 |
| Boston Scientific | 1 | $81 |
| Amgen | 5 | $72 |
| Abbott | 2 | $61 |
| Medtronic(2 entities) | 2 | $36 |
| Livanova USA, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $21 |
| Pfizer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
How this compares
$437 in reported general payments places this provider in the 65th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
See all physical medicine & rehabilitation providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 231 | $3,209 |
| Lidocaine | 22 | $634 |
| Gabapentin | 69 | $603 |
| Diclofenac Sodium | 42 | $213 |
| Cyclobenzaprine Hcl | 30 | $120 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $116 |
| Tramadol Hcl | 27 | $76 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 16 | $66 |
| Tizanidine Hcl | 14 | $52 |
| Baclofen | 14 | $45 |
| Lorazepam | 43 | $26 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Greenwood
- Karl BoellertGreenwood$257
- William LorenzFlorence$66K
- Charles NivensBluffton$25K
- Jonathan ChapekisGreer$17K
- Rebecca HoldrenGreenville$15K
- Nancey TsaiHanahan$13K
- Ashley MaybinConway$10K
- Anthony AlexanderFlorence$10K
- Eleasa HulonGreenville$10K
- Susan CramerBluffton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.